Galvanize Electrophysiology Revenue and Competitors

Location

N/A

Total Funding

Medical

Industry

Estimated Revenue & Valuation

  • Galvanize Electrophysiology's estimated annual revenue is currently $160k per year.(i)
  • Galvanize Electrophysiology's estimated revenue per employee is $32,000

Employee Data

  • Galvanize Electrophysiology has 5 Employees.(i)
  • Galvanize Electrophysiology grew their employee count by -17% last year.

Galvanize Electrophysiology's People

NameTitleEmail/Phone
1
Chief Operating OfficerReveal Email/Phone
2
Chief Financial OfficerReveal Email/Phone
3
Chief Technology OfficerReveal Email/Phone
4
VP Research And DevelopmentReveal Email/Phone
5
SVP, Regulatory and Quality AffairsReveal Email/Phone
6
SVP, Sales & Marketing, OncologyReveal Email/Phone
7
SVP, Sales & Marketing, ElectrophysiologyReveal Email/Phone
8
VP, Global Market DevelopmentReveal Email/Phone
9
Director R&DReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$8.2M2780%N/AN/A
#2
$0.3M8-33%N/AN/A
#3
$1.7M68106%N/AN/A
#4
$4M2414%$26.1MN/A
#5
$1.7M40%$1.7MN/A
#6
$7.5M2921%N/AN/A
#7
$3.5M150%$37.9MN/A
#8
$1.1M14133%N/AN/A
#9
$1.1M650%N/AN/A
#10
$3.4M20-5%N/AN/A
Add Company

What Is Galvanize Electrophysiology?

Galvanize Electrophysiology is advancing applications of pulsed electric field (PEF) technology to treat cardiac arrhythmias. Galvanize EP’s CENTAURI pulsed electric field (PEF) generator delivers high-voltage pulses in an optimized waveform to treat cardiac arrhythmias with a non-thermal ablation method that mitigates muscle stimulation and gaseous emboli. CENTAURI is currently compatible with select commercially available focal-ablation catheters and mapping systems. The CENTAURI PEF System is not available for sale in the US.

keywords:N/A

N/A

Total Funding

5

Number of Employees

$160k

Revenue (est)

-17%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.4M5150%N/A
#2
$0.4M5-17%N/A
#3
$0.2M5-17%$45.2M
#4
$0.8M50%N/A
#5
$0.4M5-29%N/A